Market Overview

Amicus Therapeutics to Present at Upcoming Scientific and Investor Conferences


CRANBURY, N.J., June 03, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced upcoming presentations at the following scientific and investor conferences in June.

Upcoming Scientific Conference:

  • Michael C. Diem, MD, Senior Vice President of Business and Corporate Development, will present at the 2019 BIO International Convention in Philadelphia, PA on Tuesday, June 4, 2019 at 2:45 p.m. ET.

Upcoming Investor Conferences:

  • Daphne Quimi, Chief Financial Officer, will present a corporate overview at the Jefferies 2019 Healthcare Conference in New York, NY on Friday, June 7, 2019 at 8:00 a.m. ET.
  • John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 40th Annual Global Healthcare Conference in Ranchos Palos Verdes, CA on Wednesday, June 12, 2019 at 8:00 a.m. PT.

A live audio webcast of the Jefferies 2019 Healthcare Conference and Goldman Sachs 40th Annual Global Healthcare Conference presentations can be accessed via the Investors section of the Amicus Therapeutics corporate website at, and will be archived for 90 days.

About Amicus Therapeutics
Amicus Therapeutics (NASDAQ:FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company's website at, and follow on Twitter and LinkedIn.


Amicus Therapeutics
Sara Pellegrino, IRC
Vice President, Investor Relations & Corporate Communications
(609) 662-5044

Amicus Therapeutics
Marco Winkler
(609) 662-2798



View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at